Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bristol-Myers Squibb Company(BMY) | 702,298 | 703,606 | +1,308 | $36.03M | $38.16M | 31.10% | +$2.12M |
| Neurocrine Biosciences, Inc.(NBIX) | 77,240 | 77,240 | 0 | $10.18M | $10.65M | 8.68% | +$475.8K |
| Biodesix, Inc.(BDSX) | 5,348,273 | 5,348,273 | 0 | $9.79M | $7.63M | 6.22% | -$2.15M |
| Elutia Inc.(ELUT) | 1,655,184 | 1,655,184 | 0 | $3.58M | $5.21M | 4.25% | +$1.64M |
| Acadia Pharmaceuticals Inc | 240,400 | 250,400 | +10,000 | $7.53M | $4.63M | 3.77% | -$2.90M |
| Ovintiv Inc.(OVV) | 84,200 | 84,200 | 0 | $3.70M | $4.37M | 3.56% | +$671.9K |
| Prothena Corp PlcSHS SHS | 169,574 | 169,574 | 0 | $6.16M | $4.20M | 3.42% | -$1.96M |
| Quidelortho Corp | 65,203 | 65,203 | 0 | $4.81M | $3.13M | 2.55% | -$1.68M |
| Silk Road Medical Inc | 158,094 | 158,094 | 0 | $1.94M | $2.90M | 2.36% | +$956.5K |
| Stoke Therapeutics, Inc.(STOK) | 210,000 | 210,000 | 0 | $1.10M | $2.83M | 2.31% | +$1.73M |
| Phreesia, Inc.(PHR) | 114,700 | 114,700 | 0 | $2.66M | $2.74M | 2.24% | +$89.5K |
| United Therapeutics Corporation(UTHR) | 11,000 | 11,000 | 0 | $2.42M | $2.53M | 2.06% | +$108.1K |
| Masimo Corp | 15,280 | 15,280 | 0 | $1.79M | $2.24M | 1.83% | +$452.9K |
| Foghorn Therapeutics Inc.(FHTX) | 320,930 | 320,930 | 0 | $2.07M | $2.15M | 1.76% | +$83.4K |
| Harrow, Inc.(HROW) | 150,000 | 150,000 | 0 | $1.68M | $1.98M | 1.62% | +$304.5K |
| DocGo Inc.(DCGO) | 150,000 | 460,000 | +310,000 | $838.5K | $1.86M | 1.51% | +$1.02M |
| Inhibrx Inc | 48,448 | 48,448 | 0 | $1.84M | $1.69M | 1.38% | -$147.3K |
| Equitrans Midstream Corporatio | 133,050 | 133,050 | 0 | $1.35M | $1.66M | 1.35% | +$307.3K |
| Axogen, Inc.(AXGN) | 173,000 | 173,000 | 0 | $1.18M | $1.40M | 1.14% | +$214.5K |
| Protagonist Therapeutics Inc | 48,000 | 48,000 | 0 | $1.10M | $1.39M | 1.13% | +$288.0K |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $1.39M | $1.35M | 1.10% | -$33.5K |
| Corcept Therapeutics Incorporated(CORT) | 50,000 | 50,000 | 0 | $1.62M | $1.26M | 1.03% | -$364.5K |
| Alphatec Holdings, Inc.(ATEC) | 88,000 | 88,000 | 0 | $1.33M | $1.21M | 0.99% | -$116.2K |
| 10x Genomics, Inc.CL A(TXG) | 30,000 | 30,000 | 0 | $1.68M | $1.13M | 0.92% | -$552.9K |
| Apellis Pharmaceuticals Inc COM | 18,000 | 18,000 | 0 | $1.08M | $1.06M | 0.86% | -$19.4K |
| Pioneer Natural Resources Co | 3,800 | 3,800 | 0 | $854.5K | $997.5K | 0.81% | +$143.0K |
| Travere Therapeutics, Inc.(TVTX) | 122,000 | 122,000 | 0 | $1.10M | $940.6K | 0.77% | -$156.2K |
| Progyny Inc | 22,000 | 22,000 | 0 | $818.0K | $839.3K | 0.68% | +$21.3K |
| Karyopharm Therapeutics Inc.(KPTI) | 469,832 | 469,832 | 0 | $406.4K | $709.4K | 0.58% | +$303.0K |
| Cytokinetics, Incorporated(CYTK) | 25,000 | 10,000 | -15,000 | $2.09M | $701.1K | 0.57% | -$1.39M |
| Coherus Oncology, Inc.(CHRS) | 110,000 | 270,000 | +160,000 | $366.3K | $645.3K | 0.53% | +$279.0K |
| Arvinas, Inc.(ARVN) | 15,000 | 15,000 | 0 | $617.4K | $619.2K | 0.50% | +$1.8K |
| Kiniksa Pharmaceuticals Ltd | 30,000 | 30,000 | 0 | $526.2K | $591.9K | 0.48% | +$65.7K |
| Kalvista Pharmaceuticals Inc | 40,000 | 46,000 | +6,000 | $490.0K | $545.6K | 0.44% | +$55.6K |
| Springworks Therapeutics Inc | 10,000 | 10,000 | 0 | $365.0K | $492.2K | 0.40% | +$127.2K |
| Keros Therapeutics, Inc.(KROS) | 7,000 | 7,000 | 0 | $278.3K | $463.4K | 0.38% | +$185.1K |
| Xenon Pharmaceuticals Inc.(XENE) | 10,000 | 10,000 | 0 | $460.6K | $430.5K | 0.35% | -$30.1K |
| Cullinan Therapeutics, Inc.(CGEM) | 25,114 | 25,114 | 0 | $255.9K | $427.9K | 0.35% | +$172.0K |
| Bluebird Bio Inc | 321,200 | 321,200 | 0 | $443.3K | $411.1K | 0.34% | -$32.1K |
| Halozyme Therapeutics, Inc.(HALO) | 10,000 | 10,000 | 0 | $369.6K | $406.8K | 0.33% | +$37.2K |
| Biohaven Pharmaceutical Holding Co Ltd | 7,365 | 7,365 | 0 | $315.2K | $402.8K | 0.33% | +$87.6K |
| G1 Therapeutics Inc | 80,000 | 80,000 | 0 | $244.0K | $345.6K | 0.28% | +$101.6K |
| Amicus Therapeutics Inc COM | 28,000 | 28,000 | 0 | $397.3K | $329.8K | 0.27% | -$67.5K |
| Sarepta Therapeutics, Inc.(SRPT) | 2,500 | 2,500 | 0 | $241.1K | $323.6K | 0.26% | +$82.6K |
| Accelerate Diagnostics Inc | 225,239 | 325,239 | +100,000 | $882.9K | $322.0K | 0.26% | -$561.0K |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 4,000 | +4,000 | $0 | $319.2K | 0.26% | +$319.2K |
| Castle Biosciences, Inc.(CSTL) | 10,000 | 14,000 | +4,000 | $215.8K | $310.1K | 0.25% | +$94.3K |
| Xencor, Inc.(XNCR) | 12,300 | 12,300 | 0 | $261.1K | $272.2K | 0.22% | +$11.1K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 16,000 | 16,000 | 0 | $242.4K | $252.2K | 0.21% | +$9.8K |
| Wave Life Sciences, Inc.SHS(WVE) | 40,000 | 40,000 | 0 | $202.0K | $246.8K | 0.20% | +$44.8K |
| Cabaletta Bio, Inc.(CABA) | 10,000 | 10,000 | 0 | $227.0K | $170.6K | 0.14% | -$56.4K |
| Gossamer Bio, Inc.(GOSS) | 138,176 | 138,176 | 0 | $126.1K | $163.0K | 0.13% | +$37.0K |
| Ventyx Biosciences Inc | 28,800 | 28,800 | 0 | $71.1K | $158.4K | 0.13% | +$87.3K |
| Liquidia Corporation(LQDA) | 20,000 | 10,000 | -10,000 | $240.6K | $147.5K | 0.12% | -$93.1K |
| 2seventy Bio Inc | 19,833 | 19,833 | 0 | $84.7K | $106.1K | 0.09% | +$21.4K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 20,000 | 20,000 | 0 | $119.8K | $101.6K | 0.08% | -$18.2K |
| InflaRx N.V.(IFRX) | 50,000 | 50,000 | 0 | $81.5K | $77.0K | 0.06% | -$4.5K |
| CERo Therapeutics Holdings, Inc.CL A(CERO) | 0 | 12,972 | +12,972 | $0 | $39.8K | 0.03% | +$39.8K |
| Yield10 Bioscience Inc | 18,750 | 18,750 | 0 | $4.5K | $7.1K | 0.01% | +$2.6K |
| Immunogen Inc | 188,000 | 0 | -188,000 | $5.57M | $0 | — | -$5.57M |